亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

CTR > 0.7 predicts the subgroup of lung adenocarcinomas ≤ 2 cm at risk of poor outcome treated by sublobar resection compared to lobar resection

医学 比例危险模型 危险系数 腺癌 生存分析 回顾性队列研究 单变量分析 全肺切除术 阶段(地层学) 外科 多元分析 内科学 胃肠病学 癌症 置信区间 古生物学 生物
作者
Weiwei Jing,Qi Li,Mengxi Liu,Yi Zhang,Sifan Chen,Ke Zhang,Dan Li,Min Zhao,Yineng Zheng,Wang-jia Li,Yangying Wu,Hongbo Xu,Ziya Zhao,Shaolei Kang,Fajin Lv
出处
期刊:Cancer Imaging [BioMed Central]
卷期号:24 (1)
标识
DOI:10.1186/s40644-024-00717-4
摘要

Abstract Background A standard surgical procedure for patients with small early-stage lung adenocarcinomas remains unknown. Hence, we aim in this study to assess the clinical utility of the consolidation-to-tumor ratio (CTR) when treating patients with small (2 cm) early stage lung cancers. Methods A retrospective cohort of 298 sublobar resection and 266 lobar resection recipients for early stage lung adenocarcinoma ≤ 2 cm was assembled from the First Affiliated Hospital of Chongqing Medical University between 2016 and 2019. To compare survival rates among the different groups, Kaplan-Meier curves were calculated, and the log-rank test was used. A multivariate Cox proportional hazard model was constructed utilizing variables that were significant in univariate analysis of survival. Results In the study, 564 patients were included, with 298 patients (52.8%) undergoing sublobar resection and 266 patients (47.2%) undergoing lobar resection. Regarding survival results, there was no significant difference in the 5-year overall survival (OS, P = 0.674) and 5-year recurrence-free survival (RFS, P = 0.253) between the two groups. Cox regression analyses showed that CTR ≥ 0.75( P < 0.001), age > 56 years ( P = 0.007), and sublobar resection( P = 0.001) could predict worse survival. After examining survival results based on CTR categorization, we segmented the individuals into three categories: CTR<0.7, 0.7 ≤ CTR<1, and CTR = 1.The lobar resection groups had more favorable clinical outcomes than the sublobar resection groups in both the 0.7 ≤ CTR < 1(RFS: P < 0.001, OS: P = 0.001) and CTR = 1(RFS: P = 0.001, OS: P = 0.125). However, for patients with 0 ≤ CTR < 0.7, no difference in either RFS or OS was found between the lobar resection and sublobar resection groups, all of which had no positive events. Patients with a CTR between 0.7 and 1 who underwent lobar resection had similar 5-year RFS and OS rates compared to those with a CTR between 0 and 0.7 who underwent sublobar resection (100% vs. 100%). Nevertheless, a CTR of 1 following lobar resection resulted in notably reduced RFS and OS when compared to a CTR between 0.7 and 1 following lobar resection ( P = 0.005 and P = 0.016, respectively). Conclusion Lobar resection is associated with better long-term survival outcomes than sublobar resection for small lung adenocarcinomas ≤ 2 cm and CTR ≥ 0.7.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
5秒前
uss完成签到,获得积分10
10秒前
LDDD发布了新的文献求助30
12秒前
领导范儿应助白华苍松采纳,获得10
40秒前
ZYD完成签到 ,获得积分10
46秒前
58秒前
斯文败类应助科研通管家采纳,获得10
58秒前
1分钟前
1分钟前
CPU完成签到 ,获得积分10
1分钟前
Bienk完成签到,获得积分10
1分钟前
震动的书兰完成签到 ,获得积分10
1分钟前
1分钟前
suozi完成签到,获得积分20
2分钟前
2分钟前
Alien发布了新的文献求助10
2分钟前
zcx完成签到,获得积分20
2分钟前
2分钟前
Warma完成签到,获得积分10
3分钟前
优雅的靖荷完成签到,获得积分10
3分钟前
123发布了新的文献求助10
3分钟前
FashionBoy应助123采纳,获得10
3分钟前
思源应助zcx采纳,获得10
4分钟前
4分钟前
4分钟前
4分钟前
科研通AI6.3应助senli2018采纳,获得10
4分钟前
4分钟前
5分钟前
5分钟前
5分钟前
Frank发布了新的文献求助10
5分钟前
suozi发布了新的文献求助10
5分钟前
senli2018发布了新的文献求助10
5分钟前
正直的超短裙完成签到,获得积分10
6分钟前
6分钟前
星星发布了新的文献求助10
6分钟前
6分钟前
6分钟前
脑洞疼应助科研通管家采纳,获得10
6分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
适配Micro-LED色转换的高兼容性量子点负性光刻胶制备与工艺研究 500
Direct and Iterative Linear System Solvers 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7311746
求助须知:如何正确求助?哪些是违规求助? 8928492
关于积分的说明 18923276
捐赠科研通 6972999
什么是DOI,文献DOI怎么找? 3213367
关于科研通互助平台的介绍 2381589
邀请新用户注册赠送积分活动 2191502